Aug 9 (Reuters)-
Medrx.Co., Ltd.
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
6 months ended 6 months ended Year to
Jun 30, 2019 Jun 30, 2018 Dec 31, 2019
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 28 mln 8 mln 1.01
(+343.9 pct) (-55.3 pct)
Operating loss 877 mln loss 575 mln loss 949 mln
Recurring loss 884 mln loss 588 mln loss 955 mln
Net loss 867 mln loss 572 mln loss 943 mln
EPS loss 77.14 yen loss 58.44 yen loss 74.18 yen
Ann Div NIL NIL
-Q2 div NIL
-Q4 div NIL NIL
NOTE - Medrx.Co., Ltd..
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4586.T